Sort
82,697 grants matching “vaccine development”
Selective Targeting of the PD-1+ HIV/SIV reservoir with novel anti-PD-1 chimeric antigen receptor T cells
$862,398Karsten Eichholz · Fred Hutchinson Cancer Center · R01 · FY2025 · AI
Project 2 - Vanderbilt University
$862,247James E Crowe · Henry M. Jackson Fdn For The Adv Mil/Med · U19 · FY2020 · AI
Project 2 - Vanderbilt University
$862,247James E Crowe · Henry M. Jackson Fdn For The Adv Mil/Med · U19 · FY2019 · AI
Blocking type I interferon signaling to reverse T cell exhaustion and control HIV-1 reservoirs
$862,217Lishan Su · Univ Of North Carolina Chapel Hill · R01 · FY2018 · AI
Molecular Basis of Dengue Virus Neutralization by Human Antibodies
$861,981Aravinda M De Silva · Univ Of North Carolina Chapel Hill · R01 · FY2016 · AI
Innate Immune Surveillance of HIV-1 During Transmission and Systemic Infection
$861,892Sumit K Chanda · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2018 · AI
Antibody-Based Protection Against Dengue Virus
$861,707Michael S. Diamond · Washington University · R01 · FY2016 · AI
Recombinant Vaccines for Prevention of AIDS and Other Diseases
$861,606Bernard Moss · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Immunologic Basis for Broad Protection against Enteric Fever Salmonella
$861,466Marcelo B. Sztein · University Of Maryland Baltimore · U19 · FY2016 · AI
Immunologic Basis for Broad Protection against Enteric Fever Salmonella
$861,464Marcelo B. Sztein · University Of Maryland Baltimore · U19 · FY2017 · AI
Immunologic Basis for Broad Protection against Enteric Fever Salmonella
$861,441Marcelo B. Sztein · University Of Maryland Baltimore · U19 · FY2018 · AI
Innate Immune Surveillance of HIV-1 During Transmission and Systemic Infection
$861,268Sumit K Chanda · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2019 · AI
Development Of Vaccines For Genital Herpes Simplex Infection
$861,221Jeffrey Cohen · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Epstein-Barr Virus Associated Disorders
$861,221Jeffrey Cohen · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Project 2. Animal studies to elucidate the optimal sequence of Env immunogens for induction of distal MPER bnAbs
$861,195S Munir Alam · Duke University · P01 · FY2021 · AI
Development of IMPDH-Targeted Drugs against Crytosporidium
$861,098Lizbeth K. Hedstrom · Brandeis University · U01 · FY2007 · AI
Overcoming pre-existing immunity to AAV to enhance AAV-based HIV immunotherapies
$861,082Mauricio De Aguiar Martins · University Of Florida · R01 · FY2024 · AI
SEQUENCE AND POLYMORPHISM OF RHESUS MACAQUE MHC
$860,972Fred Hutchinson Cancer Research Center · R24 · FY2003 · RR
Optimizing glycan shield coverage, germline B cell receptor binding and epitope diversity of V2-apex targeted HIV-1 Env immunogens
$860,928Beatrice H Hahn · University Of Pennsylvania · R37 · FY2020 · AI
Viral priming and targeting NK cells against solid tumor malignancies
$860,921Jeffrey S Miller · University Of Minnesota · R35 · FY2019 · CA
Innate Immune Surveillance of HIV-1 During Transmission and Systemic Infection
$860,913Sumit K Chanda · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2020 · AI
CD4-Independent Vaccinations for Pulmonary Infections
$860,610Jay K Kolls · Lsu Health Sciences Center · P01 · FY2007 · HL
CANDIDA ADHERENCE MYCOLOGY RESEARCH UNIT
$860,135La Biomed Res Inst/ Harbor Ucla Med Ctr · P01 · FY2000 · AI
Risk of Neonatal Vaccination for HIV/SIV Exposed Infants
$860,114Donald L Sodora · Seattle Biomedical Research Institute · R01 · FY2015 · DE
Bispecific Antibody Therapeutics for Neuroblastoma and Diffuse Midline Glioma
$860,018James M Olson · Seattle Children'S Hospital · U01 · FY2023 · CA